NewsBenzingaFull Transcript: Relmada Therapeutics Q2 2026 Earnings Call Full Transcript: Relmada Therapeutics Q2 2026 Earnings Call Benzinga 2026.10.12 11:21 (GMT+0) Open on Benzinga Other news RBC Capital Maintains Sector Perform on Merck & Co, Lowers Price Target to $145 What's Going On With Cable One Stock Monday? RBC Capital Maintains Outperform on Visteon, Lowers Price Target to $127 ASML CEO Says AI Chip Boom Could Stretch Beyond 2028, but Broadcom Warns of Financing Bottleneck RBC Capital Maintains Sector Perform on Magna International, Lowers Price Target to $68 RBC Capital Maintains Sector Perform on Lucid Group, Lowers Price Target to $4
